Publication	Data		Fish	Anatomy
Lush et al., 2019	Fig. 6		fgf3t26212/t26212	neuromast cell population proliferation increased occurrence, abnormal
	Fig. 7		fgf3t26212/t26212	neuromast sost expression decreased amount, abnormal neuromast wnt10a expression increased amount, abnormal
	Fig. 8		fgf3t26212/t26212; fb12Tg; sqet4Et ,   fgf3t26212/t26212; sqet4Et	neuromast cell population proliferation increased occurrence, abnormal neuromast cell population proliferation occurrence, ameliorated neuromast hair cell amount, ameliorated neuromast hair cell increased amount, abnormal
Reuter et al., 2019	Fig. 2.		fgf3t24152/t24152 (TU) ,   AB + MO9-fgf3	hypothalamus etv5b expression decreased amount, abnormal
	Fig. 3.		fgf3t24152/t24152 (TU) ,   AB + MO9-fgf3 ,   AB + CRISPR2-fgf3 + CRISPR3-fgf3	hypothalamus ab1-serotonin labeling decreased distribution, abnormal hypothalamus ab3-th labeling decreased distribution, abnormal hypothalamus dopaminergic neuron decreased amount, abnormal hypothalamus serotonergic neuron decreased amount, abnormal
	Fig. 4.		fgf3t24152/t24152 (TU) ,   AB + MO9-fgf3	hypothalamus avp expression decreased distribution, abnormal hypothalamus oxt expression increased distribution, abnormal
	Fig. 5.		fgf3t24152/t24152 (TU) ,   AB + MO9-fgf3	hypothalamus nkx2.4b expression decreased distribution, abnormal hypothalamus decreased size, abnormal
	Fig. 6.		AB + MO9-fgf3	hypothalamus ab11-casp3 labeling increased distribution, abnormal hypothalamus cell death increased occurrence, abnormal hypothalamus cell population proliferation decreased occurrence, abnormal
	Fig. S3		fgf3t24152/t24152 (TU) ,   AB + MO9-fgf3 ,   AB + CRISPR2-fgf3 + CRISPR3-fgf3	otolith fused with otolith, abnormal ventral mandibular arch malformed, abnormal
	Fig. S6		fgf3t24152/t24152 (TU)	hypothalamus shape, abnormal
Wang et al., 2018	Fig. 3		fgf3t24149/t24149	neuromast decreased size, abnormal
Koch et al., 2014	Fig. 9		fgf3t24152/t24152	hypothalamus posterior side has fewer parts of type dopaminergic neuron, abnormal
Maier et al., 2014	Fig. 3		fgf3t21142/t21142	macula adjacent to macula, abnormal macula fused with macula, abnormal posterior macula has extra parts of type hair cell, abnormal posterior macula increased size, abnormal
Lin et al., 2013	Fig. 3		AB + MO1-fgf3	ceratobranchial cartilage absent, abnormal ceratohyal cartilage malformed, abnormal pharyngeal arch 3-7 skeleton absent, abnormal pharyngeal arch 4 has fewer parts of type cranial neural crest, abnormal
Liu et al., 2013	Fig. 6		fgf3t24152/t24152 ,   fgf3t24152/t24152; s896Tg	adenohypophysis decreased object quality, abnormal adenohypophysis formation decreased process quality, abnormal blood vasculature lacks all parts of type hypophyseal artery, abnormal blood vasculature lacks all parts of type hypophyseal capillary, abnormal neurohypophysis innervation decreased occurrence, abnormal neurohypophysis vasculogenesis decreased occurrence, abnormal
McCarroll et al., 2013	Fig. 2		fgf3t26212/t26212; w37Tg ,   fgf3t26212/t26212	ectodermal placode development decreased process quality, abnormal facial placode poorly differentiated, abnormal head lacks all parts of type glossopharyngeal ganglion, abnormal head lacks all parts of type vagal ganglion 1, abnormal head lacks all parts of type vagal ganglion 2, abnormal head lacks all parts of type vagal ganglion 3, abnormal
	Fig. 5		fgf3t26212/t26212; nl6Tg	glossopharyngeal placode neurogenesis decreased occurrence, abnormal vagal placode 1 neurogenesis decreased occurrence, abnormal vagal placode 2 neurogenesis decreased occurrence, abnormal vagal placode 3 neurogenesis decreased occurrence, abnormal
Liu et al., 2008	Fig. 2		zf44Tg + MO1-fgf3	adenohypophysis morphogenesis process quality, abnormal pars intermedia physical object quality, abnormal
	Fig. 3		zf44Tg + MO1-fgf3	adenohypophysis morphogenesis process quality, abnormal pars intermedia physical object quality, abnormal
	Fig. 4		zf113Tg; zf44Tg + MO1-fgf3	adenohypophysis morphogenesis process quality, abnormal pars intermedia physical object quality, abnormal
	Fig. 5		zf44Tg + MO1-fgf3	adenohypophysis morphogenesis process quality, abnormal pars intermedia physical object quality, abnormal
Sperber et al., 2008	Fig. 8		fgf3unspecified	cartilage development disrupted, abnormal pharyngeal arch 3-7 morphology, abnormal
Hans et al., 2007	Fig. 7		fgf3t24149/t24149	otic vesicle decreased size, abnormal
Sun et al., 2007	Fig. 5		WT + MO1-fgf3	epibranchial field pax2a expression decreased amount, abnormal epibranchial field sox3 expression decreased amount, abnormal
Kwak et al., 2006	Fig. 7		fgf3t24152/t24152	utricle lacks parts or has fewer parts of type hair cell, abnormal
Phenotype Annotation (1994-2006)	Fig. for (t21142)		fgf3t21142/t21142 (TU)	brain quality, abnormal hypophysis quality, abnormal inner ear quality, abnormal pharyngeal arch 3-7 skeleton quality, abnormal
	Fig. for (t24149)		fgf3t24149/t24149 (TU)	brain quality, abnormal hypophysis quality, abnormal inner ear quality, abnormal pharyngeal arch 3-7 skeleton quality, abnormal
	Fig. for (t24152)		fgf3t24152/t24152	brain quality, abnormal hypophysis quality, abnormal inner ear quality, abnormal pharyngeal arch 3-7 skeleton quality, abnormal
	Fig. for (t26212)		fgf3t26212/t26212 (TU)	brain quality, abnormal hypophysis quality, abnormal inner ear quality, abnormal pharyngeal arch 3-7 skeleton quality, abnormal
Mackereth et al., 2005	Fig. 4		WT + MO1-fgf3 + MO2-fgf3	otic vesicle decreased size, abnormal otic vesicle morphogenesis process quality, abnormal
Hanaoka et al., 2004	Fig. 4		WT + MO1-fgf3	basibranchial aplastic, abnormal ceratohyal cartilage aplastic, abnormal
Nissen et al., 2003	Fig. 8		WT + MO1-fgf3	hyosymplectic cartilage hypoplastic, abnormal